Davita (NYSE:DVA) was downgraded by stock analysts at TheStreet from a “b-” rating to a “c+” rating in a report released on Thursday.
A number of other analysts also recently weighed in on DVA. Zacks Investment Research downgraded Davita from a “buy” rating to a “hold” rating in a report on Wednesday, August 1st. JPMorgan Chase & Co. upgraded Davita from an “underweight” rating to a “neutral” rating in a report on Thursday, September 13th. ValuEngine upgraded Davita from a “hold” rating to a “buy” rating in a report on Tuesday, October 9th. Raymond James downgraded Davita from a “strong-buy” rating to a “market perform” rating in a report on Thursday. Finally, Royal Bank of Canada increased their price objective on Davita from $70.00 to $78.00 and gave the company a “sector perform” rating in a report on Thursday. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $84.75.
NYSE DVA traded down $0.45 on Thursday, reaching $69.70. The company had a trading volume of 2,486,230 shares, compared to its average volume of 1,943,652. The company has a market capitalization of $12.70 billion, a price-to-earnings ratio of 20.99, a PEG ratio of 0.98 and a beta of 1.09. Davita has a fifty-two week low of $53.78 and a fifty-two week high of $80.71. The company has a quick ratio of 1.88, a current ratio of 1.90 and a debt-to-equity ratio of 1.82.
Institutional investors and hedge funds have recently modified their holdings of the business. California Public Employees Retirement System boosted its position in Davita by 8.6% during the second quarter. California Public Employees Retirement System now owns 571,830 shares of the company’s stock valued at $39,708,000 after acquiring an additional 45,102 shares during the last quarter. Hikari Tsushin Inc. boosted its position in Davita by 10.5% during the second quarter. Hikari Tsushin Inc. now owns 74,410 shares of the company’s stock valued at $5,624,000 after acquiring an additional 7,050 shares during the last quarter. Oppenheimer Asset Management Inc. bought a new stake in Davita during the second quarter valued at $3,421,000. Tibra Equities Europe Ltd bought a new stake in Davita during the second quarter valued at $1,627,000. Finally, Janus Henderson Group PLC boosted its position in Davita by 3.0% during the second quarter. Janus Henderson Group PLC now owns 1,284,092 shares of the company’s stock valued at $89,168,000 after acquiring an additional 37,362 shares during the last quarter. 87.36% of the stock is currently owned by institutional investors and hedge funds.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.